JSM2023
Back to the program
Contributed Papers

Informing Power and Sample Size Calculations in Clinical Trials

Thu, Aug 10, 10:30 AM
Jason JZ LiaoChair
Biopharmaceutical Section

6 Presentations

Covariate Adjusted Restricted Mean Survival Time Using Pseudovalue Regression to Improve Precision
10:35 AM - 10:50 AM
Yunfan Li
Co-authors: David Miller (Unlearn.ai)
Dichotomization of outcome measurements: Considerations and cautions for clinical development
10:50 AM - 11:05 AM
Audrey Boruvka (Roche)
Co-authors: Courtney Schiffman (Genentech), Maria Sbirnac (Roche)
Power gain by using the minimum order statistic in presence of independent identical trials
11:05 AM - 11:20 AM
lingjiao zhang (Johnson & Johnson)
Co-authors: Zijiang Yang (Johnson & Johnson), Fei Chen (Johnson & Johnson)
Power Simulation Program: An Adaptable Application for Assessment of Power in Planning and Pre-Data
11:20 AM - 11:35 AM
Adele Fu (Henry M Jackson Foundation)
Co-authors: Molly Malarkey (Henry M Jackson Foundation), Martin Cota (Henry M Jackson Foundation), Annabel Lee Raboy (Henry M Jackson Foundation), Noushin Mannan (Henry M Jackson Foundation), Olivia Shaw (Henry M Jackson Foundation), Nasreen Jahed (Center for Neuroscience and Regenerative Medicine), J. Kent Werner (Uniformed Services University of the Health Sciences), David Brody (Uniformed Services University of the Health Sciences), Thaddeus Haight (Center for Neuroscience and Regenerative Medicine)
Practical considerations in using win ratio for clinical trial design
11:35 AM - 11:50 AM
Huiman Barnhart (Duke University)
Co-authors: Yuliya Lokhnygina, Roland Matsouaka (Duke University), Frank Rockhold (Duke University)
Preclinical pilot trials: Information power, not statistical power
11:50 AM - 12:05 PM
Penny Reynolds (University of Florida College of Medicine)

Session participants

Elena Polverejan (Johnson & Johnson-Janssen R&D)
Participant
↑